Live Report · Updated January 21, 2026

Brookfield vs CME Group

Brookfield and CME Group are compared on this page, examining their business models, financial performance, and market context in a neutral, accessible way. The overview highlights operating structures, revenue considerations, and competitive positioning to help readers understand differences and similarities. Educational content, not financial advice.

Brookfield and CME Group are compared on this page, examining their business models, financial performance, and market context in a neutral, accessible way. The overview highlights operating structure...

Comparison Snapshot

Key Financial Metrics

BN

Metric

CME

$112.18B

Market Cap

$100.93B

12.53%

Potential Profit

1.88%

Buy

Analyst Rating

Hold

Why It's Moving

Brookfield gears up for Q4 earnings reveal amid index boost and AI infrastructure momentum.

Scheduled Q4 2025 earnings call highlights disciplined execution in private markets amid megatrends like digitalization and decarbonization.
BN.PFM added to S&P/TSX Preferred Share Index on Jan 18, boosting visibility and appeal to index-tracking investors.
Recent renewable equity program and prior AI infrastructure initiatives underscore Brookfield's aggressive push into high-growth sectors.

Sentiment:

🐃Bullish

CME Group shares climb amid record 2025 trading volumes in rates products, fueling optimism into 2026.

Rates ADV hit a yearly record of 14.2M contracts, with SOFR futures and options reaching nearly 5.4M ADV for the third straight year.
Treasury futures and options ADV soared to 8.3M with open interest at 29.6M, while 2-Year Treasury options doubled volume versus 2024.
Weekly Treasury options broke 1M ADOI and 570K ADV records, offering daily hedging tools in a volatile macro environment.

Sentiment:

🐃Bullish

Brookfield gears up for Q4 earnings reveal amid index boost and AI infrastructure momentum.

Scheduled Q4 2025 earnings call highlights disciplined execution in private markets amid megatrends like digitalization and decarbonization.
BN.PFM added to S&P/TSX Preferred Share Index on Jan 18, boosting visibility and appeal to index-tracking investors.
Recent renewable equity program and prior AI infrastructure initiatives underscore Brookfield's aggressive push into high-growth sectors.

Sentiment:

🐃Bullish

CME Group shares climb amid record 2025 trading volumes in rates products, fueling optimism into 2026.

Rates ADV hit a yearly record of 14.2M contracts, with SOFR futures and options reaching nearly 5.4M ADV for the third straight year.
Treasury futures and options ADV soared to 8.3M with open interest at 29.6M, while 2-Year Treasury options doubled volume versus 2024.
Weekly Treasury options broke 1M ADOI and 570K ADV records, offering daily hedging tools in a volatile macro environment.

Sentiment:

🐃Bullish

Investment Analysis

Brookfield

BN

Pros

Brookfield Corp benefits from diversified, long-duration real asset exposure across infrastructure, renewables, real estate, and private equity, providing resilience to economic cycles.
The company’s global scale and presence in multiple high-growth geographies enable access to proprietary deal flow and sizeable investment opportunities not available to smaller competitors.
Strong institutional partnerships and substantial third-party capital under management generate recurring, high-margin asset management fees and reduce dependence on balance sheet leverage.

Considerations

Brookfield’s elevated leverage and debt-to-equity ratio increase sensitivity to rising interest rates and refinancing risks in volatile credit markets.
Complex corporate structure and multiple subsidiaries create challenges in transparency, governance, and consistent investor communication.
Exposure to illiquid, long-term real assets may result in valuation volatility and limited flexibility during periods of market stress or liquidity contraction.

CME Group

CME

Pros

CME Group operates the world’s largest and most liquid derivatives marketplace, with a near-monopoly position in key global benchmark products for interest rates, equity indices, commodities, and FX.
The business model is highly scalable and cash-generative, driven by high-margin electronic trading, recurring clearing revenues, and minimal operational leverage in a largely fixed-cost infrastructure.
Global regulatory emphasis on central clearing and risk management supports long-term structural growth in demand for CME’s core products and services.

Considerations

CME Group’s earnings are sensitive to trading volumes, which can fluctuate significantly with macro volatility, interest rate cycles, and investor risk appetite.
The company faces increasing competition from alternative trading venues, regional exchanges, and over-the-counter markets, which may erode pricing power over time.
Regulatory changes or shifts in clearing mandates could disrupt business flows, while market structure reforms may reduce the profitability of certain legacy products.

About The Companies

Brookfield (BN)

Brookfield Corporation (ticker: BN) is a large, diversified global asset manager focused on real assets — including real estate, infrastructure, renewable power and private equity — with a market cap of about $111.87 billion. The company combines ownership of operating businesses with an expanding fee-related earnings model: it earns investment returns from long‑term holdings and management fees from funds and third‑party capital. Investors often look to Brookfield for exposure to tangible assets and growing recurring revenue as its asset-management business scales. Key considerations include sensitivity to asset valuations, leverage levels, interest rates and the illiquid nature of many underlying investments. Brookfield’s size and global reach can offer diversification benefits, but performance can vary with economic cycles and commodity or rate movements. This summary is for general educational purposes only and is not personal financial advice; investors should assess suitability, risks and fees and consider seeking independent advice.

CME Group (CME)

CME Group Inc. (CME) operates some of the world’s largest futures and options markets — including the CME, CBOT, NYMEX and COMEX exchanges — and provides clearing, market data and trading technology. Its revenues are driven by trading volumes, open interest, clearing fees and data subscriptions, making performance sensitive to market volatility, interest rates and global economic activity. Strengths include scale, deep liquidity, recurring data and clearing revenues, strong cash generation and a large market footprint. Key risks include regulatory change, competition from other exchanges and trading venues, shifts in volatility or volumes, and operational or technology issues. With a market cap near $96.8bn, CME is often viewed as a core market-structure play rather than a cyclical commodity business. This is general information for educational purposes only, not personalised investment advice; values can rise and fall and past performance is not a reliable indicator of future returns.

Brookfield (BN) Next Earnings Date

Brookfield Corp (BN) is estimated to report its next earnings on February 12, 2026, prior to market open, covering the Q4 2025 fiscal quarter. This date aligns with the company's historical pattern of mid-February releases for year-end results, though it remains unconfirmed by the company. Investors should monitor for official announcements, as estimates draw from analyst consensus and prior reporting schedules.

CME Group (CME) Next Earnings Date

CME Group's next earnings date is Wednesday, February 4, 2026, before markets open. This release will cover the fourth quarter and full year of 2025. Written highlights post at 6:00 a.m. Central Time, followed by an investor conference call at 7:30 a.m. Central Time.

Brookfield (BN) Next Earnings Date

Brookfield Corp (BN) is estimated to report its next earnings on February 12, 2026, prior to market open, covering the Q4 2025 fiscal quarter. This date aligns with the company's historical pattern of mid-February releases for year-end results, though it remains unconfirmed by the company. Investors should monitor for official announcements, as estimates draw from analyst consensus and prior reporting schedules.

CME Group (CME) Next Earnings Date

CME Group's next earnings date is Wednesday, February 4, 2026, before markets open. This release will cover the fourth quarter and full year of 2025. Written highlights post at 6:00 a.m. Central Time, followed by an investor conference call at 7:30 a.m. Central Time.

Which Baskets Do They Appear In?

Complexity Kings

Navigate the maze of corporate complexity with this carefully curated collection. Our professional analysts have identified companies whose intricate structures and opaque financial reporting potentially hide significant value that the broader market may have missed.

Published: June 17, 2025

Explore Basket

Which Baskets Do They Appear In?

Complexity Kings

Navigate the maze of corporate complexity with this carefully curated collection. Our professional analysts have identified companies whose intricate structures and opaque financial reporting potentially hide significant value that the broader market may have missed.

Published: June 17, 2025

Explore Basket

Discover More Comparisons

Brookfield vs SMBC Group

Brookfield vs SMBC Group: comparing business models

Brookfield vs Chubb

Brookfield vs Chubb: a neutral comparison

Brookfield vs BMO

Brookfield vs BMO: A neutral comparison

Brookfield vs CME Group

Comparison Snapshot

Why It's Moving

Brookfield gears up for Q4 earnings reveal amid index boost and AI infrastructure momentum.

CME Group shares climb amid record 2025 trading volumes in rates products, fueling optimism into 2026.

Brookfield gears up for Q4 earnings reveal amid index boost and AI infrastructure momentum.

CME Group shares climb amid record 2025 trading volumes in rates products, fueling optimism into 2026.